Literature DB >> 11425948

Cytoplasmic and nuclear polyglutamine aggregates in SCA6 Purkinje cells.

K Ishikawa1, K Owada, K Ishida, H Fujigasaki, M Shun Li, T Tsunemi, N Ohkoshi, S Toru, T Mizutani, M Hayashi, N Arai, K Hasegawa, T Kawanami, T Kato, T Makifuchi, S Shoji, T Tanabe, H Mizusawa.   

Abstract

Aggregations of the alpha1A-calcium channel protein have been previously demonstrated in spinocerebellar ataxia type 6 (SCA6). Here the authors show that small aggregates, labeled by a monoclonal antibody 1C2 that preferentially detects expanded polyglutamine larger than that in SCA6 mutation, are present mainly in the cytoplasm but also in the nucleus of Purkinje cells. Although the length of expansion is small in SCA6, the current finding might indicate that SCA6 conforms to the pathogenic mechanism(s) in other polyglutamine diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425948     DOI: 10.1212/wnl.56.12.1753

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Transient cerebellar alterations during development prior to obvious motor phenotype in a mouse model of spinocerebellar ataxia type 6.

Authors:  Sriram Jayabal; Lovisa Ljungberg; Alanna J Watt
Journal:  J Physiol       Date:  2016-10-02       Impact factor: 5.182

Review 2.  The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review.

Authors:  R Walsh; E Storey; D Stefani; L Kelly; V Turnbull
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 3.  Spinocerebellar degenerations: an update.

Authors:  Susan L Perlman
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

4.  Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62/sequestosome immunohistochemistry.

Authors:  Maria Pikkarainen; Päivi Hartikainen; Hilkka Soininen; Irina Alafuzoff
Journal:  Cerebellum       Date:  2011-12       Impact factor: 3.847

Review 5.  The pathogenesis of spinocerebellar ataxia.

Authors:  Arnulf H Koeppen
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

6.  Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels.

Authors:  Kei Watase; Curtis F Barrett; Taisuke Miyazaki; Taro Ishiguro; Kinya Ishikawa; Yuanxin Hu; Toshinori Unno; Yaling Sun; Sayumi Kasai; Masahiko Watanabe; Christopher M Gomez; Hidehiro Mizusawa; Richard W Tsien; Huda Y Zoghbi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

7.  DnaJ-1 and karyopherin α3 suppress degeneration in a new Drosophila model of Spinocerebellar Ataxia Type 6.

Authors:  Wei-Ling Tsou; Ryan R Hosking; Aaron A Burr; Joanna R Sutton; Michelle Ouyang; Xiaofei Du; Christopher M Gomez; Sokol V Todi
Journal:  Hum Mol Genet       Date:  2015-05-07       Impact factor: 6.150

Review 8.  Nuclear accumulation of polyglutamine disease proteins and neuropathology.

Authors:  Lauren S Havel; Shihua Li; Xiao-Jiang Li
Journal:  Mol Brain       Date:  2009-07-03       Impact factor: 4.041

9.  The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells.

Authors:  Taro Ishiguro; Kinya Ishikawa; Makoto Takahashi; Masato Obayashi; Takeshi Amino; Nozomu Sato; Masaki Sakamoto; Hiroto Fujigasaki; Fuminori Tsuruta; Ricardo Dolmetsch; Takao Arai; Hidenao Sasaki; Kazuro Nagashima; Takeo Kato; Mitsunori Yamada; Hitoshi Takahashi; Yoshio Hashizume; Hidehiro Mizusawa
Journal:  Acta Neuropathol       Date:  2009-12-31       Impact factor: 17.088

10.  Cytoplasmic location of α1A voltage-gated calcium channel C-terminal fragment (Cav2.1-CTF) aggregate is sufficient to cause cell death.

Authors:  Makoto Takahashi; Masato Obayashi; Taro Ishiguro; Nozomu Sato; Yusuke Niimi; Kokoro Ozaki; Kaoru Mogushi; Yasen Mahmut; Hiroshi Tanaka; Fuminori Tsuruta; Ricardo Dolmetsch; Mitsunori Yamada; Hitoshi Takahashi; Takeo Kato; Osamu Mori; Yoshinobu Eishi; Hidehiro Mizusawa; Kinya Ishikawa
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.